ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philippe-Primo Caimmi
Giovanni Teodori
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caimmi, P.-P.
Right arrow Articles by Teodori, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caimmi, P.-P.
Right arrow Articles by Teodori, G.
Related Collections
Right arrow Cardiac - pharmacology

Ann Thorac Surg 2006;82:e33-e34
© 2006 The Society of Thoracic Surgeons

Case Reports

Intracoronary Infusion of Levosimendan to Treat Postpericardiotomy Heart Failure

Philippe-Primo Caimmi, MD, MSa,*, Elena Grossini, MD, PhDb, Claudio Molinari, MD, PhDb, Giovanni Vacca, MDb, Giovanni Teodori, MDa

a Department of Cardiac Surgery, Ospedale Maggiore della Carità, School of Medicine, University of East Piedmont "A. Avogadro," Novara, Italy
b Department of Experimental and Clinical Medicine, University of East Piedmont "A. Avogadro," Novara, Italy

Accepted for publication June 22, 2006.

* Address correspondence to Dr Caimmi, Department of Cardiac Surgery, Ospedale Maggiore della Carità, School of Medicine, University of East Piedmont, Baluardo M. D'Azeglio n.5, 28100 Novara, Italy. (Email: philippe.caimmi{at}med.unipmn.it).

Systemic hypotension limits the intravenous use of levosimendan, particularly in coronary disease. Published reports show that the intracoronary administration of levosimendan in animal models causes an increase of coronary blood flow without systemic hypotension. In this case report, the intracoronary administration of levosimendan bolus in a 74-year-old man with postpericardiotomy heart failure elicited beneficial cardiac effects, increasing both systolic and diastolic functions and blood flow in all of the grafts. No changes of heart rate and systemic arterial blood pressure were observed.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.